hematopoietic stem cell gene therapy  (Medical School Hannover)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehematopoietic stem cell gene therapy  (Medical School Hannover)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionWiskott-Aldrich syndrome protein stimulants
TargetsWiskott-Aldrich syndrome protein
Therapy Area/IndicationsWiskott-Aldrich Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedizinische Hochschule Hannover
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedizinische Hochschule Hannover
Active IndicationsN/A
Inactive IndicationsWiskott-Aldrich Syndrome

Other Information

ATC CodeN/A
Related LinksN/A